Spatiotemporal reconstruction of the introduction of hepatitis C virus into Scotland and its subsequent regional transmission

Journal of Virology

Volumn 89, Issue 22, 2015, Pages 11223-11232

  McNaughton, Anna L ^a   Cameron, Iain Dugald ^a   Wignall Fleming, Elizabeth B ^a   Biek, Roman ^a,b   McLauchlan, John ^a   Gunson, Rory N ^c   Templeton, Kate ^d   Tan, Harriet Mei Lin ^a   Leitch, E Carol McWilliam ^a  

^a MRC UNIVERSITY OF GLASGOW CENTRE FOR VIRUS RESEARCH   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

^c GLASGOW ROYAL INFIRMARY   (United Kingdom)

^d Edinburgh Specialist Virology Centre   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; EPIDEMIOLOGICAL DATA; GENE CLUSTER; GENOTYPE; GEOGRAPHIC DISTRIBUTION; GEOGRAPHIC MAPPING; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; INTERSPERSED REPEAT; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYLOGENY; PHYLOGEOGRAPHY; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SPATIOTEMPORAL ANALYSIS; SPECIES DISTRIBUTION; UNINDEXED SEQUENCE; UNITED KINGDOM; VIRAL GENETICS; VIRUS DETECTION; VIRUS STRAIN; VIRUS TRANSMISSION; BAYES THEOREM; CARCINOMA, HEPATOCELLULAR; CLASSIFICATION; FEMALE; GENETICS; HEPACIVIRUS; LIVER NEOPLASMS; MALE; MOLECULAR GENETICS; PATHOGENICITY; SCOTLAND; SUBSTANCE ABUSE; TRANSMISSION; VIROLOGY;

ADULT; BAYES THEOREM; CARCINOMA, HEPATOCELLULAR; FEMALE; HEPACIVIRUS; HEPATITIS C; HUMANS; LIVER NEOPLASMS; MALE; MOLECULAR SEQUENCE DATA; PHYLOGEOGRAPHY; SCOTLAND; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 84945929387     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.02106-15     Document Type: Article

References (47)

1. Shepard CW, Finelli L, Alter MJ. 2005. Global epidemiology of hepatitis C virus infection. Lancet Infect Dis 5:558-567. http://dx.doi.org/10.1016/S1473-3099(05)70216-4.
2. Martin NK, Vickerman P, Grebely J, Hellard M, Hutchinson SJ, Lima VD, Foster GR, Dillon JF, Goldberg DJ, Dore GJ, Hickman M. 2013. Hepatitis C virus treatment for prevention among people who inject drugs: modelling treatment scale-up in the age of direct-acting antivirals. Hepatology 58:1598-1609. http://dx.doi.org/10.1002/hep.26431.
3. Public Health England. 2013. Hepatitis C in the UK: 2013 Report. Public Health England, London, England. http://www.hpa.org.uk/webc/HPAwebFile/HPAweb_C/1317139502302.
4. Hutchinson SJ, Bird SM, Taylor A, Goldberg DJ. 2006. Modelling the spread of hepatitis C virus infection among injecting drug users in Glasgow: implications for prevention. Int J Drug Policy 17:211-221. http://dx.doi.org/10.1016/j.drugpo.2006.02.008.
5. Anglemyer A, Rutherford GW, Baggaley RC, Egger M, Siegfried N. 2011. Antiretroviral therapy for prevention of HIV transmission in HIVdiscordant couples. Cochrane Database Syst Rev 8:CD009153. http://dx.doi.org/10.1002/14651858.CD009153.pub2.
6. Pybus OG, Rambaut A. 2009. Evolutionary analysis of the dynamics of viral infectious disease. Nat Rev Genet 10:540-550. http://dx.doi.org/10.1038/nrg2583.
7. Lemey P, Rambaut A, Drummond AJ, Suchard MA. 2009. Bayesian phylogeography finds its roots. PLoS Comput Biol 5:e10000520. http://dx.doi.org/10.1371/journal.pcbi.1000520.
8. Morelli MJ, Thebaud G, Chadoeuf J, King DP, Haydon DT, Soubeyrand S. 2012. A Bayesian inference framework to reconstruct transmission trees using epidemiological and genetic data. PLoS Comput Biol 8:e1002768. http://dx.doi.org/10.1371/journal.pcbi.1002768.
9. Azman AS, Luquero FJ, Rodrigues A, Palma PP, Grais RF, Banga CN, Grenfell BT, Lessler J. 2012. Urban cholera transmission hotspots and their implications for reactive vaccination: evidence from Bissau City, Guinea Bissau. PLoS Negl Trop Dis 6:e1901. http://dx.doi.org/10.1371/journal.pntd.0001901.
10. Sacks-Davis R, Daraganova G, Aitken C, Higgs P, Tracy L, Bowden S, Jenjinson R, Rolls D, Pattison P, Robins G, Grebely J, Barry A, Hellard M. 2012. Hepatitis C virus phylogenetic clustering is associated with the social-injecting network in a cohort of people who inject drugs. PLoS One 7:e47335. http://dx.doi.org/10.1371/journal.pone.0047335.
11. Romano CM, Guedes de Carvalho-Mello IMV, Jamal LF, Lucas de Melo F, Motoki M, Pinho JRR, Holmes E, de Andrade Zanotto MP, the VGDN Consortium. 2010. Social networks shape the transmission dynamics of hepatitis C virus. PLoS One 5:e11170. http://dx.doi.org/10.1371/journal.pone.0011170.
12. Simmonds P. 2012. SSE: a nucleotide and amino acid sequence analysis platform. BMC Res Notes 5:50. http://dx.doi.org/10.1186/1756-0500-5-50.
13. Drummond AJ, Suchard MA, Dong X, Rambaut A. 2012. Bayesian phylogenetics with BEAUti and the BEAST 1.7. Mol Biol Evol 29:1969-1973. http://dx.doi.org/10.1093/molbev/mss075.
14. Rambaut A, Suchard MA, Xie D, Drummond AJ. 2014. Tracer v1.6. http://beast.bio.ed.ac.uk/Tracer.
15. Hasegawa M, Kishino H, Yano T. 1985. Dating of the human-ape splitting by a molecular clock of mitochondrial DNA. J Mol Evol 22:160-174. http://dx.doi.org/10.1007/BF02101694.
16. Drummond AJ, Rambaut A, Shapiro B, Pybus OG. 2005. Bayesian coalescent inference of past population dynamics from molecular sequences. Mol Biol Evol 22:1185-1192. http://dx.doi.org/10.1093/molbev/msi103.
17. Gray RR, Parker J, Lemey P, Salemi M, Katzourakis A, Pybus OG. 2011. The mode and tempo of hepatitis C virus evolution within and among hosts. BMC Evol Biol 11:131-140. http://dx.doi.org/10.1186/1471-2148-11-131.
18. Magiorkinis G, Magiorkinis E, Paraskevis D, Ho SYW, Shapiro B, Pybus OG, Alain J-P, Hatzakis A. 2009. The global spread of hepatitis C virus 1a and 1b: a phylodynamic and phylogeographic analysis. PLoS Med 6:e1000198. http://dx.doi.org/10.1371/journal.pmed.1000198.
19. Yuan M, Lu T, Li C, Lu L. 2013. The evolutionary rates of HCV estimated with subtype 1a and 1b sequences over the ORF length and in different genomic regions. PLoS One 8:e64698. http://dx.doi.org/10.1371/journal.pone.0064698.
20. Zehender G, Sorrentino C, Lai A, Ebranati E, Gabanelli E, Lo Presti A, Vojosevic D, Lausevic D, Terzic D, Shkjezi R, Bino S, Vratnica Z, Mugosa B, Galli M, Ciccozzi M. 2013. Reconstruction of the evolutionary dynamics of hepatitis C virus subtypes in Montenegro and the Balkan region. Infect Genet Evol 17:223-230. http://dx.doi.org/10.1016/j.meegid.2013.04.003.
21. Rehman IU, Idrees M, Ali M, Liaqat A, Butt S, Hussain A, Akbar H, Afzal S. 2011. Hepatitis C virus genotype 3a with phylogenetically distinct origin is circulating in Pakistan. Genet Vaccines Ther 9:2. http://dx.doi.org/10.1186/1479-0556-9-2.
22. Khan A, Tanaka Y, Azam Z, Abbas Z, Kurbanov F, Saleem U, Hamid S, Jafri W, Mizokami M. 2009. Epidemic spread of hepatitis C virus genotype 3a and relation to high incidence of hepatocellular carcinoma in Pakistan. J Med Virol 81:1189-1197. http://dx.doi.org/10.1002/jmv.21466.
23. Pybus OG, Markov PV, Wu A, Tatem AJ. 2007. Investigating the endemic transmission of the hepatitis C virus. Int J Parasitol 37:839-849. http://dx.doi.org/10.1016/j.ijpara.2007.04.009.
24. Leslie S, Winney B, Hellenthal G, Davison D, Boumertit A, Day T, Hutnik K, Royrvik EC, Cunliffe B, Wellcome Trust Case Control Consortium, International Multiple Sclerosis Genetics Consortium, Lawson DJ, Falush D, Freeman C, Pirinen M, Myers S, Robinson M, Donnelly P, Bodmer W. 2015. The fine-scale genetic structure of the British population. Nature 519:309-314. http://dx.doi.org/10.1038/nature14230.
25. McNaughton AL, Thomson EC, Templeton K, Gunson RN, Leitch ECM. 2014. Mixed genotype hepatitis C infections and implications for treatment. Hepatology 59:1209. http://dx.doi.org/10.1002/hep.26544.
26. Sacks-Davis R, McBryde E, Grebely J, Hellard M, Vickerman P. 2014. Many hepatitis Creinfections that spontaneously clear may be undetected: Markov-chain Monte Carlo analysis of observational study data. J R Soc Interface 12:20141197. http://dx.doi.org/10.1098/rsif.2014.1197.
27. Schroter M, Feucht H-H, Zollner B, Schafer P, Laufs R. 2003. Multiple infections with different HCV genotypes: prevalence and clinical impact. J Clin Virol 27:200-204. http://dx.doi.org/10.1016/S1386-6532(02)00264-0.
28. Buckton AJ, Ngui S-L, Arnold C, Boast K, Kovacs J, Klapper PE, Patel B, Ibrahim I, Rangarajan S, Ramsay ME, Teo C-G. 2006. Multitypic hepatitis Cvirus infection identified by real-time nucleotide sequencing of minority genotypes. J Clin Microbiol 44:2779-2784. http://dx.doi.org/10.1128/JCM.01638-05.
29. Butt S, Idrees M, Ur Rehman I, Akbar H, Shahid M, Afzal S, Younas S, Amin I. 2011. Mixed genotype infections with hepatitis C virus, Pakistan. Emerg Infect Dis 17:1565-1566. http://dx.doi.org/10.3201/eid1708.100950.21801655.
30. Lee Y-M, Chen Y-J, Lee C-M, Kuo L-H, Wong W-W, Chen Y-MA. 2011. Detection of hepatitis C virus subtypes 6a, 6n, 6w and mixed infections using a modified multiplex real-time polymerase chain reaction protocol. J Formosan Med Assoc 110:762-767. http://dx.doi.org/10.1016/j.jfma.2011.11.006.
31. van de Laar TJW, Molenkamp R, van den Berg C, Schinkel J, Beld MGHM, Prins M, Coutinho RA, Bruisten SM. 2009. Frequent HCV reinfection and superinfection in a cohort of injecting drug users in Amsterdam. J Hepatol 51:667-674. http://dx.doi.org/10.1016/j.jhep.2009.05.027.
32. Pham ST, Bull RA, Bennett JM, Rawlinson WD, Dore GJ, Lloyd AR, White PA. 2010. Frequent multiple hepatitis C virus infections among injection drug users in a prison setting. Hepatology 52:1564-1572. http://dx.doi.org/10.1002/hep.23885.
33. Herring BL, Page-Shafer K, Tobler LH, Delwart EL. 2004. Frequent hepatitis C virus superinfection in injection drug users. J Infect Dis 190: 1396-1403. http://dx.doi.org/10.1086/424491.
34. Cochrane A, Searle B, Hardie A, Robertson R, Delahooke T, Cameron S, Tedder RS, Dusheiko GM, de Lamballerie X, Simmonds P. 2002. A genetic analysis of hepatitis C virus transmission between injection drug users. J Infect Dis 186:1212-1221. http://dx.doi.org/10.1086/344314.
35. Hope VD, Hickman M, Ngui SL, Jones S, Telfer M, Bizzarri M, Ncube F, Parry JV. 2011. Measuring the incidence, prevalence and genetic relatedness of hepatitis C infections among a community recruited sample of injecting drug users, using dried blood spots. J Viral Hepat 18:262-270. http://dx.doi.org/10.1111/j.1365-2893.2010.01297.x.
36. Oliveira MDLA, Bastos FI, Telles PR, Hacker MDA, Oliveira SAND, Miguel JC, Yoshida CFT. 2009. Epidemiological and genetic analyses of hepatitis C virus transmission among young/short-and long-term injecting drug users from Rio de Janeiro, Brazil. J Clin Virol 44:200-206. http://dx.doi.org/10.1016/j.jcv.2008.12.008.
37. Matthews GV, Pham ST, Hellard M, Grebely J, Zhang L, Oon A, Marks P, van Beek I, Rawlinson W, Kaldor JM, Lloyd A, Dore GJ, White PA, the ATAHC Study Group. 2011. Patterns and characteristics of hepatitis C transmission clusters among HIV-positive and HIV-negative individuals in the Australian Trial in Acute Hepatitis C. Clin Infect Dis 52:803-811. http://dx.doi.org/10.1093/cid/ciq200.
38. Jacka B, Applegate T, Krajden M, Olmstead A, Harrigan PR, Marshall BDL, DeBeck K, Milloy MJ, Lamoury F, Pybus OG, Lima VD, Magiorkinis G, Montoya V, Montaner J, Joy J, Woods C, Dobrer S, Dore GJ, Poon AFY, Grebely J. 2014. Phylogenetic clustering of hepatitis C virus among people who inject drugs in Vancouver, Canada. Hepatology 60: 1571-1580. http://dx.doi.org/10.1002/hep.27310.
39. Maher L, Li J, Jalaludin B, Chant KG, Kaldor JM. 2007. High hepatitis C incidence in new injecting drug users: a policy failure? Aust N Z J Public Health 31:30-35. http://dx.doi.org/10.1111/j.1753-6405.2007.00007.x.
40. Taylor A, Goldberg D, Hutchinson S, Cameron S, Gore SM, Mc-Menamin J, Green S, Pithie A, Fox R. 2000. Prevalence of hepatitis C virus infection among injecting drug users in Glasgow 1990-1996: are current harm reduction strategies working? J Infect 40:176-183. http://dx.doi.org/10.1053/jinf.2000.0647.
41. Hickman M, Hope V, Brady T, Madden P, Jones S, Holloway G, Ncube F, Parry J. 2007. Hepatitis C virus (HCV) prevalence and injecting risk behaviour in multiple sites in England in 2004. J Viral Hepat 14:645-652. http://dx.doi.org/10.1111/j.1365-2893.2007.00855.x.
42. Harris M, Rhodes T. 2013. Hepatitis C treatment access and uptake for people who inject drugs: a review mapping the role of social factors. Harm Reduct J 10:7. http://dx.doi.org/10.1186/1477-7517-10-7.
43. Campo DS, Dimitrova Z, Yamasaki L, Skums P, Lau DTY, Vaughan G, Forbi JC, Teo C-G, Khudyakov Y. 2014. Next-generation sequencing reveals large connected networks of intra-host HCV variants. BMC Genomics 15(Suppl 5):S4. http://dx.doi.org/10.1186/1471-2164-15-S5-S4.
44. Kundu S, Lockwood J, Depledge DP, Chaudhry Y, Aston A, Rao K, Hartley JC, Goodfellow I, Breuer J. 2013. Next-generation whole genome sequencing identifies the direction of norovirus transmission in linked patients. Clin Infect Dis 57:407-414. http://dx.doi.org/10.1093/cid/cit287.
45. Redd AD, Wendel SKJ, Longosz AF, Fogel JM, Dadabhai S, Kumwenda N, Sun J, Walker MP, Bruno D, Martens C, Eshleman SH, Porcella SF, Quinn TC, Taha TE. 2015. Evaluation of postpartum HIV superinfection and mother-to-child transmission. AIDS 29:1567-1573. http://dx.doi.org/10.1097/QAD.0000000000000740.
46. Ramirez S, Perez-del-Pulgar S, Carrion JA, Coto-Llerena M, Mensa L, Dragun J, Garcia-Valdecasas JC, Navasa M, Forns X. 2010. Hepatitis C superinfection of liver grafts: a detailed analysis of early exclusion of nondominant virus strains. J Gen Virol 91:1183-1188. http://dx.doi.org/10.1099/vir.0.018929-0.
47. Ohtsuru S, Ueda Y, Marusawa H, Inuzuka T, Nishijima N, Nasu A, Shimizu K, Koike K, Uemoto S, Chiba T. 2013. Dynamics of defective hepatitis C virus clones in reinfected liver transplant recipients: ultradeep sequencing analysis. J Clin Microbiol 51:3645-3652. http://dx.doi.org/10.1128/JCM.00676-13.